IRIS

Aroclor 1254

CASRN 11097-69-1 | DTXSID5020100

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (26 pp, 167 K) Last Updated: 10/01/1994

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Immune, Dermal, Ocular 2 x 10 -5 Ocular exudate, inflamed and prominent Meibomian glands, distorted growth of finger and toe nails; decreased antibody (IgG and IgM) response to sheep erythrocytes LOAEL : 5 x 10-3
mg/kg-day
300 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (26 pp, 167 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (26 pp, 167 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (26 pp, 167 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (26 pp, 167 K)

Not assessed under the IRIS Program.


Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.